Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of the extent of previous endoscopic sinus surgery using the ACCESS score in patients with chronic rhinosinusitis referred to tertiary care rhinologic clinics.

Rhinology·2026
Same author

Rifampicin drug monitoring in TB patients: new evidence for increased dosage?

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study.

Journal of endocrinological investigation·2024
Same author

Molecular study of the presence and transcriptional activity of HPV in semen.

Journal of endocrinological investigation·2023
Same author

Disturbance of primary producer communities disrupts the thermal limits of the associated aquatic fauna.

The Science of the total environment·2023
Same author

Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study.

Journal of endocrinological investigation·2022
Same journal

Glycolysis and neutrophil extracellular traps in atherosclerosis: Mechanisms, association, and therapeutic strategies.

International journal of immunopathology and pharmacology·2026
Same journal

Development of RNase P ribozyme-based therapy against oral herpesvirus infections by HSV-1 and KSHV.

International journal of immunopathology and pharmacology·2026
Same journal

Liposomal nanotherapeutics for cancer treatment: Targeted delivery and immunotherapy.

International journal of immunopathology and pharmacology·2026
Same journal

Apoptosis enhancement in MCF-7 cells: Synergistic effects of doxorubicin and the novel sulfonamide Zm-093.

International journal of immunopathology and pharmacology·2026
Same journal

Primary epithelioid angiosarcoma of thyroid: A case report and review of literature.

International journal of immunopathology and pharmacology·2026
Same journal

Retraction: Adipose stem cells' antagonism in glycosylation of D-galactose-induced skin aging of nude mice and its skin recovery function.

International journal of immunopathology and pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Insights into infectious otitis media.

P Marchisio1, S Bianchini, P Capaccio

  • 1Departments of Mother and Child, University of Milan, Policlinico, Mangiagalli e Regina Elena, Milan, Italy.

International Journal of Immunopathology and Pharmacology
|February 16, 2010
PubMed
Summary
This summary is machine-generated.

Otitis media, a common childhood illness, is caused by multiple factors. Recent research offers new insights into its microbiology, potentially improving treatment and prevention strategies for this public health concern.

Related Experiment Videos

Last Updated: Jun 16, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Area of Science:

  • Otolaryngology
  • Pediatrics
  • Microbiology

Background:

  • Otitis media is a significant public health issue, frequently diagnosed in children.
  • It causes immediate and long-term health problems (morbidity).
  • Established knowledge on risk factors and microbiology has remained consistent for years.

Purpose of the Study:

  • To present recent findings on the microbiological aspects of otitis media.
  • To explore how new data can inform therapeutic and preventive strategies.

Main Methods:

  • Review of recent research and data on otitis media microbiology.
  • Analysis of emerging trends in understanding the disease's causative agents.

Main Results:

  • New data have emerged regarding the diverse microbiological landscape of otitis media.
  • These findings expand upon previous, long-standing knowledge.

Conclusions:

  • Recent microbiological insights offer potential for novel therapeutic interventions.
  • This evolving knowledge is crucial for developing advanced preventive strategies against otitis media.